UPDATE 2-FDA delays decision on Human Genome lupus drug By: Reuters: Company News December 03, 2010 at 17:17 PM EST * Human Genome shares fall 4 percent (Adds original action date, requested data submitted, updates share price) Read More >> Related Stocks: Gsk Plc ADR